World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
11597
World Ranking
15000
National Ranking
6276

Overview

Gilbert J. Cote is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on multiple areas within medicine and molecular biology, with particular attention to cancer and endocrinology.

Their recent publications highlight work in thyroid cancer and cancer genomics, including:

  • "Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019" (2020) published in JAMA Oncology
  • "Advances in Targeting RET-Dependent Cancers" (2020) published in Cancer Discovery
  • "Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma" (2022) published in JCO Precision Oncology
  • "Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma" (2021) published in Thyroid
  • "Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers" (2021) published in Molecular Cancer Therapeutics

Their frequent co-authors include Ramona Dadu, Maria E. Cabanillas, Mark Zafereo, Naifa L. Busaidy, and Jennifer Wang. These collaborators have contributed to several publications alongside Cote.

Gilbert J. Cote has published repeatedly in several academic venues, notably:

  • Endocrine Related Cancer
  • JAMA Oncology
  • Cancer Discovery
  • JCO Precision Oncology
  • Molecular Cancer Therapeutics

The main fields of study for their research encompass Medicine and Biochemistry, Genetics and Molecular Biology. Specific subfields include Endocrinology, Diabetes and Metabolism, Epidemiology, Cancer Research, Genetics, and Oncology.

Their principal research topics cover areas such as:

  • Thyroid Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Genetic factors in colorectal cancer
  • BRCA gene mutations in cancer
  • Neuroendocrine Tumor Research Advances
  • Pancreatic and Hepatic Oncology Research

Best Publications

  • The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

    Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir

  • Exon definition may facilitate splice site selection in RNAs with multiple exons.

    Barbara L. Robberson;Gilbert J. Cote;Susan M. Berget

  • Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy

    Pamela M. Thomas;Gilbert J. Cote;Nelson Wohllk;Bassem Haddad

  • A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.

    Timo Otonkoski;Carina Ämmälä;Hanna Huopio;Hanna Huopio;Gilbert J. Cote

  • Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: Primary tumor size and primary tumor location as prognostic indicators

    Montserrat Ayala-Ramirez;Lei Feng;Marcella M. Johnson;Shamim Ejaz

  • RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.

    Maria A. Kouvaraki;Suzanne E. Shapiro;Nancy D. Perrier;Gilbert J. Cote

  • Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.

    Libero Santarpia;Adel K. El-Naggar;Gilbert J. Cote;Jeffrey N. Myers

  • Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.

    N. Wohllk;G. J. Cote;M. M. J. Bugalho;N. Ordonez

  • EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

    Weiwei Yang;Yan Xia;Yu Cao;Yanhua Zheng

  • Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene

    Ana O. Hoff;Philip Catala-Lehnen;Pamela M. Thomas;Matthias Priemel

  • Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity

    Liping Zhang;Ana O. Hoff;Sunil J. Wimalawansa;Gilbert J. Cote

  • Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.

    Maria A. Kouvaraki;Suzanne E. Shapiro;Gilbert Cote;Jeffrey E Lee

  • Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

    Camilo Jiménez;Gilbert Cote;Andrew Arnold;Robert F. Gagel

  • PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.

    Jennifer R. Molina;Nitin K. Agarwal;Fabiana C. Morales;Yuho Hayashi

  • Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

    Maria A. Kouvaraki;Jeffrey E. Lee;Suzanne E. Shapiro;Robert F. Gagel

  • A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation

    Xinjian Li;Xu Qian;Li Xia Peng;Yuhui Jiang;Yuhui Jiang

  • Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.

    Sarika N. Rao;Mark Zafereo;Ramona Dadu;Naifa L. Busaidy

  • Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines

    Hannah C. Cheung;Tao Hai;Wen Zhu;Keith A. Baggerly

  • Advances in Targeting RET-Dependent Cancers.

    Vivek Subbiah;Gilbert J. Cote

  • Fibroblast Growth Factor Receptor-1 α-Exon Exclusion and Polypyrimidine Tract-binding Protein in Glioblastoma Multiforme Tumors

    Wei Jin;Ian E. McCutcheon;Gregory N. Fuller;Eileen S.C. Huang

Frequent Co-Authors

Robert F. Gagel
Robert F. Gagel The University of Texas MD Anderson Cancer Center
Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
Steven I. Sherman
Steven I. Sherman The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Wei Jin
Wei Jin Hong Kong Polytechnic University
Zhimin Lu
Zhimin Lu Zhejiang University
Jeffrey N. Myers
Jeffrey N. Myers The University of Texas MD Anderson Cancer Center
Charles Lu
Charles Lu The University of Texas MD Anderson Cancer Center
Erich M. Sturgis
Erich M. Sturgis Baylor College of Medicine
Ralf Krahe
Ralf Krahe The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to diverse careers in research, education, and healthcare. Many graduates also pursue specialized roles where medical and data knowledge overlap—such as health information management or medical coding.

For those interested in the medical data field, understanding the differences between ccs certification and other credentials is crucial. Certification choices can impact both your job prospects and earning potential.

Careers like medical coding are popular for their flexibility and remote work opportunities. If you’re curious about how much does a medical coder make, you’ll find that salaries vary by experience, certification, and location.

The career outlook is positive, but you may wonder, is medical coding a dying career? Industry trends show that as healthcare systems become more digital, demand for skilled professionals remains steady.

If you want a flexible, affordable start in this field, consider earning your degree remotely. Several of the online health information management degree programs offer both convenience and solid career pathways.

Best Scientists Citing Gilbert J. Cote

Trending Scientists